journal article·2025-11

Functional connectivity biomarkers of mild cognitive impairment predict recognition memory improvement through transcranial magnetic stimulation intervention

Zhiwei Guo, Yi Jiang, Jiayuan He, Ning Jiang

Publisher page

Abstract

Previous studies have demonstrated the positive effects of repetitive transcranial magnetic stimulation (rTMS) on the memory function of patients with mild cognitive impairment (MCI). However, the efficacy of rTMS exhibits individual variability, and the reasons for which (and the potential neural mechanisms) remain unclear. The aim of this study was to investigate neuroimaging biomarkers that can be used to predict the efficacy of rTMS treatment in MCI. Resting-state functional magnetic resonance imaging data were collected from 53 participants with MCI before and after the completion of 10-day high-frequency rTMS. Baseline intra- and inter-functional connectivity of the resting-state networks of responders and nonresponders was computed and compared to identify potential neural predictors of the variability in response to rTMS. The predictive value of individual and combined neural predictors was also assessed. Baseline intra-functional connectivity in the right parahippocampal gyrus of the hippocampal network (HN) and left precuneus of the default mode network (DMN) was significantly different between responders and nonresponders, as was inter-functional connectivity between the HN and the salience network (SN). These intra- and inter-functional connectivities were significantly correlated with the changes in recognition memory after rTMS seen in patients with MCI (r= −0.564, −0.322, and 0.289). The combination of these indicators showed the best classification performance for responders and nonresponders (sensitivity = 94%, specificity = 86%). These results suggest that functional connectivity within the HN and DMN, and between the HN and SN, is predictive of the treatment response to rTMS.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Functional Brain Connectivity Studies · EEG and Brain-Computer Interfaces · Transcranial Magnetic Stimulation Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. Alzheimer’s Disease International. World Alzheimer Report 2024: Global Changes in Attitudes to Dementia. Report, Alzheimer’s Disease International. 2024
2. 2024 Alzheimer’s disease facts and figures. Alzheimers Dement, 2024, 20: 3708–382110.1002/alz.13809 ↗
3. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet, 2006, 367: 1262–127010.1016/S0140-6736(06)68542-5 ↗
4. Petersen R C. Clinical practice. Mild cognitive impairment. N Engl J Med, 2011, 364: 2227–223410.1056/NEJMcp0910237 ↗
5. Petersen E R, Oturai A B, Koch-Henriksen N, et al. Smoking affects the interferon beta treatment response in multiple sclerosis. Neurology, 2018, 90: 126–13510.1212/WNL.0000000000004949 ↗
6. Ward A, Tardiff S, Dye C, et al. Rate of conversion from prodromal Alzheimer’s disease to Alzheimer’s dementia: A systematic review of the literature. Dement Geriatr Cogn Disord Extra, 2013, 3: 320–33210.1159/000354370 ↗
7. Budd Haeberlein S, Aisen P S, Barkhof F, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J Prevention Alzheimers Dis, 2022, 9: 197–21010.14283/jpad.2022.30 ↗
8. Sims J R, Zimmer J A, Evans C D, et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA, 2023, 330: 512–52710.1001/jama.2023.13239 ↗
9. Yoon C, Groff C, Criss O. Lecanemab: A second in class therapy for the management of early Alzheimer’s disease. Innov Pharm, 2024, 15: 1010.24926/iip.v15i1.5787 ↗
10. Porsteinsson A P, Isaacson R S, Knox S, et al. Diagnosis of early Alzheimer’s disease: Clinical practice in 2021. J Prevention Alzheimers Dis, 2021, 8: 371–38610.14283/jpad.2021.23 ↗
11. Xu X, Li W, Mei J, et al. Feature selection and combination of information in the functional brain connectome for discrimination of mild cognitive impairment and analyses of altered brain patterns. Front Aging Neurosci, 2020, 12: 2810.3389/fnagi.2020.00028 ↗
12. Chu C S, Li C T, Brunoni A R, et al. Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer’s disease and mild cognitive impairment: A component network meta-analysis. J Neurol Neurosurg Psychiatry, 2021, 92: 195–20310.1136/jnnp-2020-323870 ↗
13. Yang T, Liu W, He J, et al. The cognitive effect of non-invasive brain stimulation combined with cognitive training in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis. Alzheimers Res Ther, 2024, 16: 14010.1186/s13195-024-01505-9 ↗
14. Iimori T, Nakajima S, Miyazaki T, et al. Effectiveness of the pre-frontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer’s disease: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry, 2019, 88: 31–4010.1016/j.pnpbp.2018.06.014 ↗
15. Liao X, Li G, Wang A, et al. Repetitive transcranial magnetic stimulation as an alternative therapy for cognitive impairment in Alzheimer’s disease: A meta-analysis. J Alzheimer Dis, 2015, 48: 463–47210.3233/JAD-150346 ↗
16. Lin Y, Jiang W J, Shan P Y, et al. The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer’s disease: A systematic review and meta-analysis. J Neurol Sci, 2019, 398: 184–19110.1016/j.jns.2019.01.038 ↗
17. Wang X, Mao Z, Ling Z, et al. Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer’s disease: A meta-analysis of randomized controlled trials. J Neurol, 2020, 267: 791–80110.1007/s00415-019-09644-y ↗
18. Chou Y, Ton That V, Sundman M. A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging, 2020, 86: 1–1010.1016/j.neurobiolaging.2019.08.020 ↗
19. Menardi A, Dotti L, Ambrosini E, et al. Transcranial magnetic stimulation treatment in Alzheimer’s disease: A meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization. J Neurol, 2022, 269: 5283–530110.1007/s00415-022-11236-2 ↗
20. Gu L, Xu H, Qian F. Effects of non-invasive brain stimulation on Alzheimer’s disease. J Prevention Alzheimers Dis, 2022, 9: 410–42410.14283/jpad.2022.40 ↗
21. Yan Y, Tian M, Wang T, et al. Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer’s disease: A systematic review and meta-analysis. Front Neurol, 2023, 14: 120920510.3389/fneur.2023.1209205 ↗
22. Zhang X, Lan X, Chen C, et al. Effects of repetitive transcranial magnetic stimulation in patients with mild cognitive impairment: A meta-analysis of randomized controlled trials. Front Hum Neurosci, 2021, 15: 72371510.3389/fnhum.2021.723715 ↗
23. Xie Y, Li Y, Nie L, et al. Cognitive enhancement of repetitive transcranial magnetic stimulation in patients with mild cognitive impairment and early Alzheimer’s disease: A systematic review and meta-analysis. Front Cell Dev Biol, 2021, 9: 73404610.3389/fcell.2021.734046 ↗
24. Pan P L, Zhu L, Yu T T, et al. Aberrant spontaneous low-frequency brain activity in amnestic mild cognitive impairment: A meta-analysis of resting-state fMRI studies. Ageing Res Rev, 2017, 35: 12–2110.1016/j.arr.2016.12.001 ↗
25. Zheng D, Xia W, Yi Z Q, et al. Alterations of brain local functional connectivity in amnestic mild cognitive impairment. Transl Neurodegener, 2018, 7: 2610.1186/s40035-018-0134-8 ↗
26. Gu L, Zhang Z. Exploring structural and functional brain changes in mild cognitive impairment: A whole brain ALE meta-analysis for multimodal MRI. ACS Chem Neurosci, 2019, 10: 2823–282910.1021/acschemneuro.9b00045 ↗
27. Yeung M K, Chau A K, Chiu J Y, et al. Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis. Ageing Res Rev, 2022, 80: 10167510.1016/j.arr.2022.101675 ↗
28. Tang T, Huang L, Zhang Y, et al. Aberrant pattern of regional cerebral blood flow in mild cognitive impairment: A meta-analysis of arterial spin labeling magnetic resonance imaging. Front Aging Neurosci, 2022, 14: 96134410.3389/fnagi.2022.961344 ↗
29. Wang T, Yan S, Lu J. The effects of noninvasive brain stimulation on cognitive function in patients with mild cognitive impairment and Alzheimer’s disease using resting-state functional magnetic resonance imaging: A systematic review and meta-analysis. CNS Neurosci Ther, 2023, 29: 3160–317210.1111/cns.14314 ↗
30. Chen H, Li M, Qin Z, et al. Functional network connectivity patterns predicting the efficacy of repetitive transcranial magnetic stimulation in the spectrum of Alzheimer’s disease. Eur Radiol Exp, 2023, 7: 6310.1186/s41747-023-00376-3 ↗
31. Petersen R C. Mild cognitive impairment as a diagnostic entity. J Internal Med, 2004, 256: 183–19410.1111/j.1365-2796.2004.01388.x ↗
32. Bell A J, Sejnowski T J. An information-maximization approach to blind separation and blind deconvolution. Neural Comput, 1995, 7: 1129–115910.1162/neco.1995.7.6.1129 ↗
33. Du W, Ma S, Fu G-S, et al. A novel approach for assessing reliability of ICA for fMRI analysis. In: Proceedings of the 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP). Florence, 2014. 2084–2088
34. Calhoun V D, Adali T, Pearlson G D, et al. A method for making group inferences from functional MRI data using independent component analysis. Hum Brain Mapp, 2001, 14: 140–15110.1002/hbm.1048 ↗
35. Jiang L, Cui H, Zhang C, et al. Repetitive transcranial magnetic stimulation for improving cognitive function in patients with mild cognitive impairment: A systematic review. Front Aging Neurosci, 2021, 12: 59300010.3389/fnagi.2020.593000 ↗
36. Kumar S, Zomorrodi R, Ghazala Z, et al. Extent of dorsolateral pre-frontal cortex plasticity and its association with working memory in patients with Alzheimer disease. JAMA Psychiatry, 2017, 74: 1266–127410.1001/jamapsychiatry.2017.3292 ↗
37. He X, Qin W, Liu Y, et al. Abnormal salience network in normal aging and in amnestic mild cognitive impairment and Alzheimer’s disease. Hum Brain Mapp, 2014, 35: 3446–346410.1002/hbm.22414 ↗
38. Xue C, Sun H, Yue Y, et al. Structural and functional disruption of salience network in distinguishing subjective cognitive decline and amnestic mild cognitive impairment. ACS Chem Neurosci, 2021, 12: 1384–139410.1021/acschemneuro.1c00051 ↗
39. Song Y, Xu W, Chen S, et al. Functional MRI-specific alterations in salience network in mild cognitive impairment: An ALE meta-analysis. Front Aging Neurosci, 2021, 13: 69521010.3389/fnagi.2021.695210 ↗
40. Chand G B, Thakuri D S, Soni B. Salience network anatomical and molecular markers are linked with cognitive dysfunction in mild cognitive impairment. J NeuroImag, 2022, 32: 728–73410.1111/jon.12980 ↗
41. Yang C, Gao X, Liu N, et al. Convergent and distinct neural structural and functional patterns of mild cognitive impairment: A multimodal meta-analysis. Cerebral Cortex, 2023, 33: 8876–888910.1093/cercor/bhad167 ↗
42. Gao S L, Yue J, Li X L, et al. Multimodal magnetic resonance imaging on brain network in amnestic mild cognitive impairment: A mini-review. Medicine, 2023, 102: e3499410.1097/MD.0000000000034994 ↗
43. Xue C, Qi W, Yuan Q, et al. Disrupted dynamic functional connectivity in distinguishing subjective cognitive decline and amnestic mild cognitive impairment based on the triple-network model. Front Aging Neurosci, 2021, 13: 71100910.3389/fnagi.2021.711009 ↗
44. Zhang M, Guan Z, Zhang Y, et al. Disrupted coupling between salience network segregation and glucose metabolism is associated with cognitive decline in Alzheimer’s disease—A simultaneous resting-state FDG-PET/fMRI study. NeuroImage-Clin, 2022, 34: 10297710.1016/j.nicl.2022.102977 ↗
45. Zhan Y, Ma J, Alexander-Bloch A F, et al. Longitudinal study of impaired intra- and inter-network brain connectivity in subjects at high risk for Alzheimer’s disease. J Alzheimer Dis, 2016, 52: 913–92710.3233/JAD-160008 ↗
46. Chand G B, Wu J, Hajjar I, et al. Interactions of the salience network and its subsystems with the default-mode and the central-executive networks in normal aging and mild cognitive impairment. Brain Connect, 2017, 7: 401–41210.1089/brain.2017.0509 ↗
47. Cheung E Y W, Chau A C M, Shea Y F, et al. Level of Amyloid-β (Aβ) binding leading to differential effects on resting state functional connectivity in major brain networks. Biomedicines, 2022, 10: 232110.3390/biomedicines10092321 ↗
48. Mondragón J D, Marapin R, De Deyn P P, et al. Short- and long-term functional connectivity differences associated with Alzheimer’s disease progression. Dement Geriatr Cogn Disord Extra, 2022, 11: 235–24910.1159/000518233 ↗
49. Zhang Y, Li C, Chen D, et al. Repeated high-definition transcranial direct current stimulation modulated temporal variability of brain regions in core neurocognitive networks over the left dorsolateral pre-frontal cortex in mild cognitive impairment patients. J Alzheimer Dis, 2022, 90: 655–66610.3233/JAD-220539 ↗
50. Na H R, Lim J S, Kim W J, et al. Multimodal assessment of neural substrates in computerized cognitive training: A preliminary study. J Clin Neurol, 2018, 14: 454–46310.3988/jcn.2018.14.4.454 ↗
51. Porto F H G, Coutinho A M, de Souza Duran F L, et al. Aerobic training modulates salience network and default mode network metabolism in subjects with mild cognitive impairment. NeuroImageClin, 2018, 19: 616–624
52. Won J, Nielson K A, Smith J C. Large-scale network connectivity and cognitive function changes after exercise training in older adults with intact cognition and mild cognitive impairment. J Alzheimers Dis Rep, 2023, 7: 399–41310.3233/ADR-220062 ↗
53. Yin Z, Zhou J, Xia M, et al. Acupuncture on mild cognitive impairment: A systematic review of neuroimaging studies. Front Aging Neurosci, 2023, 15: 100743610.3389/fnagi.2023.1007436 ↗
54. Ma J, Wu J J, Xing X X, et al. Circuit-based neuromodulation enhances delayed recall in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry, 2024, 95: jnnp–2023–333152
55. He H, Shang Y, Yang X, et al. Constructing an associative memory system using spiking neural network. Front Neurosci, 2019, 13: 65010.3389/fnins.2019.00650 ↗
56. Khadka S, Chung J J, Tumer K. Neuroevolution of a modular memory-augmented neural network for deep memory problems. Evolary Comput, 2019, 27: 639–66410.1162/evco_a_00239 ↗
57. Yang Z, Zhuang X, Sreenivasan K, et al. A robust deep neural network for denoising task-based fMRI data: An application to working memory and episodic memory. Med Image Anal, 2020, 60: 10162210.1016/j.media.2019.101622 ↗
58. Soldner J, Meindl T, Koch W, et al. Strukturelle und funktionelle neuronale Konnektivität bei der Alzheimer-Krankheit. Nervenarzt, 2012, 83: 878–88710.1007/s00115-011-3326-3 ↗
59. Liu J, Zhang X, Yu C, et al. Impaired parahippocampus connectivity in mild cognitive impairment and Alzheimer’s disease. J Alzheimer Dis, 2016, 49: 1051–106410.3233/JAD-150727 ↗
60. Christopher L, Duff-Canning S, Koshimori Y, et al. Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann Neurol, 2015, 77: 269–28010.1002/ana.24323 ↗
61. Hu Y, Du W, Zhang Y, et al. Loss of parietal memory network integrity in Alzheimer’s disease. Front Aging Neurosci, 2019, 11: 6710.3389/fnagi.2019.00067 ↗